These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7678506)

  • 1. Variability of plasma apolipoprotein (apo) A-II levels associated with an apo A-II gene polymorphism in monozygotic twin pairs.
    Thorn JA; Stocks J; Reichl D; Alcolado JC; Chamberlain JC; Galton D
    Biochim Biophys Acta; 1993 Jan; 1180(3):299-303. PubMed ID: 7678506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MspI restriction fragment length polymorphism 3' to the apolipoprotein A-II gene: relationships with lipids, apolipoproteins, and premature coronary artery disease.
    Civeira F; Genest J; Pocovi M; Salem DN; Herbert PN; Wilson PW; Schaefer EJ; Ordovas JM
    Atherosclerosis; 1992 Feb; 92(2-3):165-76. PubMed ID: 1352975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity.
    Vohl MC; Lamarche B; Bergeron J; Moorjani S; Prud'homme D; Nadeau A; Tremblay A; Lupien PJ; Bouchard C; Després JP
    Atherosclerosis; 1997 Feb; 128(2):183-90. PubMed ID: 9050775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MspI polymorphism of the apolipoprotein A-II gene, serum lipids and apolipoproteins in Chinese from Singapore.
    Saha N; Tan JA; Tay JS
    Hum Hered; 1992; 42(5):293-7. PubMed ID: 1281133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels.
    Wang XL; Badenhop R; Humphrey KE; Wilcken DE
    Genet Epidemiol; 1996; 13(1):1-10. PubMed ID: 8647374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA polymorphisms in linkage disequilibrium at the 3' end of the human APO AII gene: relationships with lipids, apolipoproteins and coronary heart disease.
    Dupuy-Gorce AM; Desmarais E; Vigneron S; Buresi C; Nicaud V; Evans A; Luc G; Arveiler D; Marqués-Vidal P; Cambien F; Tiret L; Crastes de Paulet A; Roizés G
    Clin Genet; 1996 Oct; 50(4):191-8. PubMed ID: 9001797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
    Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
    Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease.
    Reguero JR; Cubero GI; Batalla A; Alvarez V; Hevia S; Cortina A; Coto E
    Cardiology; 1998 Dec; 90(3):231-5. PubMed ID: 9892774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of the XbaI, EcoRI, PvuII and MspI polymorphisms of the apolipoprotein B gene in relation to hypercholesterolaemia in the general population.
    Series JJ; Gaffney D; Packard CJ; Shepherd J
    Clin Chim Acta; 1993 Apr; 215(1):89-98. PubMed ID: 7685667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A genome-wide association study of monozygotic twin-pairs suggests a locus related to variability of serum high-density lipoprotein cholesterol.
    Surakka I; Whitfield JB; Perola M; Visscher PM; Montgomery GW; Falchi M; Willemsen G; de Geus EJ; Magnusson PK; Christensen K; Sørensen TI; Pietiläinen KH; Rantanen T; Silander K; Widén E; Muilu J; Rahman I; Liljedahl U; Syvänen AC; Palotie A; Kaprio J; Kyvik KO; Pedersen NL; Boomsma DI; Spector T; Martin NG; Ripatti S; Peltonen L;
    Twin Res Hum Genet; 2012 Dec; 15(6):691-9. PubMed ID: 23031429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ser447-Ter mutation of the lipoprotein lipase gene relates to variability of serum lipid and lipoprotein levels in monozygotic twins.
    Thorn JA; Needham EW; Mattu RK; Stocks J; Galton DJ
    J Lipid Res; 1998 Feb; 39(2):437-41. PubMed ID: 9508003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction fragment length polymorphism of the human apo B and apo AII gene regions among type II diabetics.
    Ghusn H; Arem R; Frazier M; Chamakhi S; Ezzaouia G; Chan L
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):25-32. PubMed ID: 8865367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein B amino acid 3611 substitution from arginine to glutamine creates the Ag (h/i) epitope: the polymorphism is not associated with differences in serum cholesterol and apolipoprotein B levels.
    Xu CF; Nanjee N; Tikkanen MJ; Huttunen JK; Pietinen P; Bütler R; Angelico F; Del Ben M; Mazzarella B; Antonio R
    Hum Genet; 1989 Jul; 82(4):322-6. PubMed ID: 2472350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase chain reaction (PCR) for detection of MspI polymorphism at the D3S3 locus.
    Ganly PS; Douglas J; Rabbitts PH
    Nucleic Acids Res; 1991 Jul; 19(13):3759. PubMed ID: 1712943
    [No Abstract]   [Full Text] [Related]  

  • 16. [DNA polymorphisms of apolipoprotein A I gene in Chinese endogenous hypertriglyceridemics].
    Zhang Q; Liu B; Liu Y; Fan P; Zhang R; Wu Z; Fu M; Galton DJ
    Hua Xi Yi Ke Da Xue Xue Bao; 1997 Sep; 28(3):233-8. PubMed ID: 10684023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study.
    Talmud PJ; Ye S; Humphries SE
    Genet Epidemiol; 1994; 11(3):265-80. PubMed ID: 8088507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCR detection of the MspI (Aa) RFLP at the human phenylalanine hydroxylase (PAH) locus.
    Wedemeyer N; Dworniczak B; Horst J
    Nucleic Acids Res; 1991 Apr; 19(8):1959. PubMed ID: 1709499
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymerase chain reaction (PCR) for detection of MspI polymorphism at the D3S6 locus.
    Ganly PS; Douglas J; Rabbitts PH
    Nucleic Acids Res; 1991 Jul; 19(13):3759. PubMed ID: 1712944
    [No Abstract]   [Full Text] [Related]  

  • 20. The underlying molecular mechanism of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease.
    Contois JH; Anamani DE; Tsongalis GJ
    Clin Lab Med; 1996 Mar; 16(1):105-23. PubMed ID: 8867586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.